Investment Summary

ShawKwei & Partners Invests In Group14

On September 25, 2023, private equity firm ShawKwei & Partners invested in manufacturer Group14

Investment Highlights
  • This is ShawKwei & Partners’ 1st transaction in the Manufacturing sector.
  • This is ShawKwei & Partners’ 3rd transaction in the United States.
  • This is ShawKwei & Partners’ 1st transaction in Washington.

Investment Summary
Date 2023-09-25
Target Group14
Sector Manufacturing
Investor(s) ShawKwei & Partners
Deal Type Growth Capital

Target

Group14

Woodinville, Washington, United States
Group14 is a global manufacturer and supplier of advanced silicon battery materials that enable the electrification of everything from tiny medical, consumer, and commercial devices to every possible flavor and size of transportation. The company brings new finely-tuned performance capabilities to the era of the lithium-silicon battery. Group14 was founded in 2015 and is based in Woodinville, Washington.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

ShawKwei & Partners

Investor Investor Investor

Category Private Equity Firm
Founded 1999
Size Small
Type Sector Agnostic
DESCRIPTION

ShawKwei & Partners is a private equity firm focused on opportunities across the greater China region. The Firm takes an active role with investments and generally targets significant ownership stakes in middle-market manufacturing and service companies. ShawKwei & Partners was established in 1999 and is headquartered in Hong Kong.

DEAL STATS #
Overall 12 of 12
Sector (Manufacturing) 1 of 1
Type (Growth Capital) 4 of 4
State (Washington) 1 of 1
Country (United States) 3 of 3
Year (2023) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-09-07 ZymeFlow

Houston, Texas, United States

ZymeFlow engages in the decontamination of hydrocarbon process equipment for entry, inspection, and maintenance including hot work. The exclusive ZymeFlow Process uses proprietary chemistry and application to achieve vessel entry in 8-12 hours. This unparalleled process prepares equipment for entry by simultaneously de-oiling while eliminating pyrophoric iron sulfide (FeS), hydrogen sulfide (H2S), benzene, and other explosive gases (LELs). ZymeFlow was founded in 2002 and is based in Houston, Texas.

Buy -
Mergr

Product

Company

Legal